162 related articles for article (PubMed ID: 2361584)
41. Blood component collection and transfusion.
Hester JP; McCredie KB; Freireich EJ; Kellogg RM; Mulzet A
Compr Ther; 1979 Feb; 5(2):59-62. PubMed ID: 428208
[No Abstract] [Full Text] [Related]
42. The technique of therapeutic apheresis. Removal of abnormal blood elements may succeed when all else fails.
McLeod BC
J Crit Illn; 1991 May; 6(5):487-95. PubMed ID: 10147917
[TBL] [Abstract][Full Text] [Related]
43. Applications and limitations of hemapheresis.
Silvergleid AJ
Annu Rev Med; 1983; 34():69-89. PubMed ID: 6344778
[TBL] [Abstract][Full Text] [Related]
44. [Principles and methods of using apparatus for plasmocytapheresis with donors and patients].
Kalinin NN
Probl Gematol Pereliv Krovi; 1981 Jun; 26(6):11-6. PubMed ID: 7279882
[No Abstract] [Full Text] [Related]
45. [Therapeutic plasmapheresis].
Dvoretskiĭ LI; Vorob'ev PA; Ryzhko VV
Ter Arkh; 1984; 56(6):137-44. PubMed ID: 6382670
[No Abstract] [Full Text] [Related]
46. Blood transfusions: how to administer whole blood and its components.
Nursing; 1980 Mar; 10(3):67-9. PubMed ID: 6898911
[No Abstract] [Full Text] [Related]
47. Successful removal of Chlamydia pneumoniae from plateletpheresis products collected using automated leukoreduction hemapheresis techniques.
Webley W; Stuart E; Cirino F; Cahill F; Stec T; Andrzejewski C
J Clin Apher; 2006 Oct; 21(3):195-201. PubMed ID: 16570261
[TBL] [Abstract][Full Text] [Related]
48. [Ambulatory treatment and check-ups of patients with hematologic diseases].
Kovaleva LG
Klin Med (Mosk); 1989 Aug; 67(8):127-32. PubMed ID: 2811233
[No Abstract] [Full Text] [Related]
49. Effect of plateletpheresis on complete blood count values using three different cell separator systems in healthy donors.
Beyan C; Cetin T; Kaptan K; Nevruz O
Transfus Apher Sci; 2003 Aug; 29(1):45-7. PubMed ID: 12877892
[TBL] [Abstract][Full Text] [Related]
50. Comparison of COBE white cell-reduction and standard plateletpheresis protocols in the same donors.
Zingsem J; Zimmermann R; Weisbach V; Glaser A; van Waeg G; Eckstein R
Transfusion; 1997 Oct; 37(10):1045-9. PubMed ID: 9354823
[TBL] [Abstract][Full Text] [Related]
51. Health risks to cytapheresis donors.
Westphal RG
Clin Haematol; 1984 Feb; 13(1):289-301. PubMed ID: 6202448
[TBL] [Abstract][Full Text] [Related]
52. Apheresis practice patterns in the United States of America: Analysis of a market claims database.
Zantek ND; Martinez RJ; Johnson AD; Tholkes AJ; Shah S
J Clin Apher; 2021 Oct; 36(5):750-758. PubMed ID: 34252989
[TBL] [Abstract][Full Text] [Related]
53. Advances in apheresis therapy for glomerular diseases.
Yokoyama H; Wada T; Zhang W; Yamaya H; Asaka M
Clin Exp Nephrol; 2007 Jun; 11(2):122-127. PubMed ID: 17593511
[TBL] [Abstract][Full Text] [Related]
54. [Effects of granulocyte and platelet collection by semicontinuous plasmapheresis equipment (Hemonetics model 30) on blood donors: with special reference to the effects of high molecular hydroxyethyl starch].
Shimoyama M; Minato K; Kitahara T
Rinsho Ketsueki; 1981 Oct; 22(10):1661-6. PubMed ID: 6174751
[No Abstract] [Full Text] [Related]
55. The professional nurse in the cell support unit.
Wood L; Richards JD; Jacobs P
Curationis; 1984 Jun; 7(2):30-3. PubMed ID: 6565525
[No Abstract] [Full Text] [Related]
56. Evaluation of granulocyte-releasing products and chemiluminescence during cytapheresis.
Lindena J; Sommerfeld U; Burkhardt H; Aulmann HM
Transfusion; 1989 Jun; 29(5):424-8. PubMed ID: 2786654
[TBL] [Abstract][Full Text] [Related]
57. [Cell-plasmapheresis--indications and risks].
Heinrichs C; Blauärmel O
Z Arztl Fortbild (Jena); 1980 May; 74(9):410-5. PubMed ID: 7434810
[No Abstract] [Full Text] [Related]
58. Use of heparin in the continuous flow centrifuge (CFC) during cytapheresis and plasmapheresis.
Morales-Polanco MR; Pizzuto-Chávez J; Ambríz-Fernández R; Avilés-Miranda A; Sinco-Angeles A
Arch Invest Med (Mex); 1983; 14(2):93-105. PubMed ID: 6639260
[No Abstract] [Full Text] [Related]
59. [Multiple apheresis].
Coffe C
Transfus Clin Biol; 2007 May; 14(1):86-9. PubMed ID: 17521944
[TBL] [Abstract][Full Text] [Related]
60. Dosage and scheduling regimens for glucocorticoids.
Winton EF; Vogler WR; Mishler JM
J Clin Apher; 1983; 1(3):144-8. PubMed ID: 6546052
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
